Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,467.20", "chg": -4.45, "chgp": "-0.08%", "dir": -1, "prev_price": "5,471.65", "mcapval": "66,449.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "May 19", "curr_time": "", "bse_nse_vol": "1.09 lacs", "exc_status": "Active", "traded_date": "May 19, 2026", "traded_date_str": "2026 05 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3996079", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_valuationdot_3996079.png", "date": "2026-05-18 08:02:35", "description": "Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price-to-earnings (P/E) and price-to-book value (P/BV) ratios in the context of historical trends and peer comparisons, providing investors with a comprehensive view of the stock’s current price attractiveness within the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Declines 1.64% Amid Valuation Shift and Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-164-amid-valuation-shift-and-downgrade-3994356", "imagepath": "", "date": "2026-05-16 13:10:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Valuation grade shifts from attractive to fair amid strong market returns</p>\n <p><strong>12 May:</strong> Downgrade to Sell rating citing valuation and financial concerns</p>\n <p><strong>15 May:</strong> Week closes at Rs.5,485.25 (-1.64%) vs Sensex -2.63%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,576.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,485.25</div><div class=\"stat-change negative\">-1.64%</div></div>\n ..." }, { "title": "Alkem Laboratories Downgraded to Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-valuation-and-financial-concerns-3986908", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_mojoScore_3986908.png", "date": "2026-05-12 08:49:44", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 May 2026. This shift reflects a reassessment across key parameters including valuation, financial trends, quality metrics, and technical indicators, signalling caution for investors despite the company’s respectable market performance over the long term." }, { "title": "Alkem Laboratories Ltd Valuation Shifts to Fair Amidst Strong Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-to-fair-amidst-strong-market-returns-3984695", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_valuationdot_3984695.png", "date": "2026-05-11 08:02:15", "description": "Alkem Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a competitive pharmaceutical sector landscape. With a current price of ₹5,576.80 and a modest day decline of 0.25%, investors are reassessing the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks." }, { "title": "Alkem Laboratories Gains 4.14%: 3 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-gains-414-3-key-factors-driving-the-weekly-move-3983228", "imagepath": "", "date": "2026-05-09 14:01:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Technical momentum shifts amid mixed signals</p>\n <p><strong>5 May:</strong> Upgrade to Hold rating on improved valuation and technicals</p>\n <p><strong>5 May:</strong> Valuation parameters signal renewed price attractiveness</p>\n <p><strong>8 May:</strong> Week closes at Rs.5,576.80 (+4.14%) outperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,355.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-val..." }, { "title": "Alkem Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Valuation and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-improved-valuation-and-technicals-3975294", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_mojoScore_3975294.png", "date": "2026-05-05 08:51:49", "description": "Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improvements in valuation metrics and technical indicators despite flat recent financial performance. The mid-cap pharmaceutical company’s revised Mojo Score of 50.0 and Hold grade mark a significant shift driven by a combination of factors including enhanced valuation attractiveness, evolving technical trends, stable financial fundamentals, and solid quality parameters." }, { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3974658", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_valuationdot_3974658.png", "date": "2026-05-05 08:01:18", "description": "Alkem Laboratories Ltd has witnessed a notable improvement in its valuation parameters, prompting a reclassification from a Sell to a Hold rating with an upgraded valuation grade from fair to attractive. This shift reflects a more compelling price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the pharmaceutical sector’s mid-cap landscape." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3973770", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlkemLaboratori_technicaldot_3973770.png", "date": "2026-05-04 08:02:17", "description": "Alkem Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of late April 2026. Despite a modest day gain of 1.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments and what they imply for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Gains 3.35%: 5 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-gains-335-5-key-factors-driving-the-weeks-mixed-momentum-3971534", "imagepath": "", "date": "2026-05-02 13:03:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Sharp open interest surge and 2.29% price gain</p>\n <p><strong>28 Apr:</strong> Formation of Death Cross and technical downgrade</p>\n <p><strong>29 Apr:</strong> Mojo Grade downgraded to Sell amid valuation concerns</p>\n <p><strong>30 Apr:</strong> Bearish momentum intensifies with 1.26% price decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,228.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,40..." } ], "total": 564, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "08-May-2026", "details": "This is to Inform you regarding US FDA inspection conducted today at the Company s CRO facility located at Taloja.", "source": "BSE" }, { "caption": "Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.", "datetime": "05-May-2026", "details": "Please find Attached herewith Disclosure under Regulation 30 of SEBI(LODR) 2015.", "source": "BSE" }, { "caption": "US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman", "datetime": "02-May-2026", "details": "Please find attached herewith Intimation about US FDA Inspection at Company s manufacturing facility located at Amaliya Daman.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26", "dt": "2026-02-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

4 May: Technical momentum shifts amid mixed signals

5 May: Upgrade to Hold rating on improved valuation and technicals

5 May: Valuation parameters signal renewed price attractiveness

8 May: Week closes at Rs.5,576.80 (+4.14%) outperforming Sensex

Week Open

Rs.5,355.20

Week Close

Read full news article

Alkem Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Valuation and Technicals

2026-05-05 08:51:49

Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting improvements in valuation metrics and technical indicators despite flat recent financial performance. The mid-cap pharmaceutical company’s revised Mojo Score of 50.0 and Hold grade mark a significant shift driven by a combination of factors including enhanced valuation attractiveness, evolving technical trends, stable financial fundamentals, and solid quality parameters.

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-05 08:01:18

Alkem Laboratories Ltd has witnessed a notable improvement in its valuation parameters, prompting a reclassification from a Sell to a Hold rating with an upgraded valuation grade from fair to attractive. This shift reflects a more compelling price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the pharmaceutical sector’s mid-cap landscape.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-04 08:02:17

Alkem Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of late April 2026. Despite a modest day gain of 1.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments and what they imply for investors navigating the Pharmaceuticals & Biotechnology sector.